EarlyHall Conference intelligence Get a sample

Niche event · Biotech partnering · Regulatory & market access

FT Global Pharma and Biotech Summit 2026

Dates
10–11 Nov 2026
Where
Convene 22 Bishopsgate, London, United Kingdom
Attendees
350
350+, organizer figure, no edition given
Exhibitors
Count not published
Tickets
From £3,499
Format
In person and online

Organized by Financial Times (FT Live) · Official site · Checked 22 Oct 2026 against the organizer's pages · Sources

What it is

A two-day Financial Times conference in London for pharma and biotech leaders. The 2026 program covers European competitiveness, US drug pricing after the Most Favored Nation rules, AI, direct access to medicines, China's growing role and the future of the NHS. It is a content-led summit with a small in-person room, not an exhibition.

Who attends

Senior executives and decision-makers from pharma, biotech, government, investment and the wider life sciences sector. Announced speakers include the CEO of the MHRA, the president of development and chief medical officer at Novartis, GSK's chief AI officer, the director general of EFPIA, the chief executive of the ABPI and the CEO of BioMarin. The organizer lists 350+ attendees, 60+ speakers and FT journalists, 260+ companies and 20+ countries.

Go ifGo if you sell to pharma or biotech leadership and want a small room of senior people, with a networking app to book meetings before you arrive. It suits policy, market access, strategy, AI and dealmaking offers where a conversation with an executive matters more than booth traffic.

Who exhibits and sponsors

A sample from the official 2026 exhibitor and sponsor list.

Official lists: Sponsors Speakers

FT Global Pharma and Biotech Summit: common questions

When and where is FT Global Pharma and Biotech Summit 2026?

FT Global Pharma and Biotech Summit 2026 runs 10–11 Nov 2026 in London, United Kingdom, at Convene 22 Bishopsgate.

How much does FT Global Pharma and Biotech Summit cost?
  • Supplier Pass: GBP 3,499 plus VAT, the pass for vendors
  • Pharma & Biotech Pass: GBP 2,499 plus VAT, for pharma and biotech companies
  • Both passes include in-person sessions and networking drinks
Who attends FT Global Pharma and Biotech Summit?

Senior executives and decision-makers from pharma, biotech, government, investment and the wider life sciences sector. Announced speakers include the CEO of the MHRA, the president of development and chief medical officer at Novartis, GSK's chief AI officer, the director general of EFPIA, the chief executive of the ABPI and the CEO of BioMarin. The organizer lists 350+ attendees, 60+ speakers and FT journalists, 260+ companies and 20+ countries.

Is there an exhibitor list for FT Global Pharma and Biotech Summit?

The organizer has not published a public exhibitor list for this edition yet.

Can I get the attendee list for FT Global Pharma and Biotech Summit?

Organizers rarely publish one. EarlyHall builds it from public sources: exhibitor and speaker pages and social posts, plus the event app when you give us access. Each person is tagged with their role at the event and the source we found them in, and a listing is never presented as confirmed attendance. Lists start at $349 per event.

More pharma & life sciences events

Book the coffee before you book the flight.

Within 3 business days, we send back 10 FT Global Pharma and Biotech Summit attendees who fit your offer, with the reason each one qualifies.

Within 3 business days, by email. No call needed.

Your sample request is saved. We will email your sample within 3 business days. Reply to that email if you would like to book a call.